Marker Discovery and Validation
The Diagnostic Biomarkers and Technologies Branch (DBTB) supports research that correlates molecular properties of tumors with important clinical characteristics of people with cancer to identify new cancer markers. Approaches may include the use of genomic, pathologic, and proteomic technologies, including:
- Comparative genomic hybridization (CGH)
- Single nucleotide polymorphism (SNP) analysis
- Epigenetic analysis
- cDNA arrays
- mRNA splicing analysis
- DNA mutation analysis
- miRNA expression analysis
- immunohistochemical analysis (IHC)
- in situ hybridization
- protein arrays studies
- MALDI-TOF analysis
Studies may include the use of human tissue samples, tissue microarrays, human cancer cell lines, human tumor xenografts, and animal models. Studies are supported through investigator-initiated R01 applications.
Experimental Studies of Interest
- Cancer Detection
- Cancer Diagnosis
- Disease Progression
- Disease Recurrence
- Patient Survival
- Response to Therapy